| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Epileptology, University of Bonn, Germany.
Address correspondence and reprint requests to Dr. Markus Reuber, Department of Epileptology, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, F. R. Germany; e-mail: mreuber{at}doctors.org.uk
Delay to diagnosis was studied in 313 consecutive patients with psychogenic nonepileptic seizures (PNES). On average, patients with PNES were diagnosed 7.2 years after manifestation (SD 9.3 years). Younger age, interictal epileptiform potentials in the EEG, and anticonvulsant treatment were associated with longer delays. Other patient factors did not explain the great variability of the time to diagnosis, suggesting that physician factors contributed to delays.
This article has been cited by other articles:
|
|
 |
|
  W. C. LaFrance Jr., A. S. Blum, I. W. Miller, C. E. Ryan, and G. I. Keitner Methodological Issues in Conducting Treatment Trials for Psychological Nonepileptic Seizures J Neuropsychiatry Clin Neurosci, November 1, 2007; 19(4): 391 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Reuber, S. Howlett, A. Khan, and R. A. Grunewald Non-Epileptic Seizures and Other Functional Neurological Symptoms: Predisposing, Precipitating, and Perpetuating Factors Psychosomatics, June 1, 2007; 48(3): 230 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. LaFrance Jr and S. R. Benbadis Avoiding the costs of unrecognized psychological nonepileptic seizures Neurology, June 13, 2006; 66(11): 1620 - 1621. [Full Text] [PDF]
|
|
|
|
 |
|
 M Oto, C Espie, A Pelosi, M Selkirk, and R Duncan The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1682 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J D C Mellers The approach to patients with "non-epileptic seizures" Postgrad. Med. J., August 1, 2005; 81(958): 498 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Reuber, A J Mitchell, S J Howlett, H L Crimlisk, and R A Grunewald Functional symptoms in neurology: questions and answers J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 307 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Duncan, M Oto, A J C Russell, and P Conway Pseudosleep events in patients with psychogenic non-epileptic seizures: prevalence and associations J. Neurol. Neurosurg. Psychiatry, July 1, 2004; 75(7): 1009 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Millan, D. Cussac, A. Gobert, F. Lejeune, J.-M. Rivet, C. M. La Cour, A. Newman-Tancredi, and J.-L. Peglion S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: I. Cellular, Electrophysiological, and Neurochemical Profile in Comparison with Ropinirole J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 903 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Millan, B. Di Cara, M. Hill, M. Jackson, J. N. Joyce, J. Brotchie, S. McGuire, A. Crossman, L. Smith, P. Jenner, et al. S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: II. Actions in Rodent, Primate, and Cellular Models of Antiparkinsonian Activity in Comparison to Ropinirole J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 921 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Millan, M. Brocco, M. Papp, F. Serres, C. D. La Rochelle, T. Sharp, J.-L. Peglion, and A. Dekeyne S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 936 - 950. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
